0001104659-18-054173.txt : 20180829 0001104659-18-054173.hdr.sgml : 20180829 20180829172218 ACCESSION NUMBER: 0001104659-18-054173 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180827 FILED AS OF DATE: 20180829 DATE AS OF CHANGE: 20180829 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Hoffman Michael B CENTRAL INDEX KEY: 0001290208 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36020 FILM NUMBER: 181045000 BUSINESS ADDRESS: BUSINESS PHONE: (203) 413-2200 MAIL ADDRESS: STREET 1: 1 GREENWICH OFFICE PARK CITY: GREENWICH STATE: CT ZIP: 06831 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Onconova Therapeutics, Inc. CENTRAL INDEX KEY: 0001130598 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 375 PHEASANT RUN CITY: NEWTOWN STATE: PA ZIP: 18940 BUSINESS PHONE: 267-759-3681 MAIL ADDRESS: STREET 1: 375 PHEASANT RUN CITY: NEWTOWN STATE: PA ZIP: 18940 FORMER COMPANY: FORMER CONFORMED NAME: ONCONOVA THERAPEUTICS, INC. DATE OF NAME CHANGE: 20090526 FORMER COMPANY: FORMER CONFORMED NAME: ONCONOVA THERAPEUTICS INC DATE OF NAME CHANGE: 20001226 4 1 a4.xml 4 X0306 4 2018-08-27 0 0001130598 Onconova Therapeutics, Inc. ONTX 0001290208 Hoffman Michael B 53 EAST 83 STREET NEW YORK NY 10028 1 0 0 0 Common Stock 2018-08-27 4 S 0 20000 0.4535 D 5811116 I By the Michael and Jane Hoffman 2018 Descendants Trust Common Stock 2018-08-28 4 S 0 20000 0.4445 D 5791116 I By the Michael and Jane Hoffman 2018 Descendants Trust Common Stock 2018-08-28 4 S 0 30000 0.4569 D 5761116 I By the Michael and Jane Hoffman 2018 Descendants Trust Common Stock 2018-08-29 4 S 0 29999.262 0.4507 D 5731116.738 I By the Michael and Jane Hoffman 2018 Descendants Trust These shares are held for the benefit of the reporting person's descendants. The reporting person's spouse is a trustee of the trust. The reporting person is a general agent of the trust. Includes (i) 19,951 options to purchase shares of Common Stock of the Issuer, which are immediately exercisable or will be exercisable within 60 days of the date hereof; (ii) 5,700,836.738 shares of Common Stock held by the Michael and Jane Hoffman 2018 Descendants Trust, of which Mr. Hoffman is donor (which includes 2,211,765 shares of Common Stock issuable upon the exercise of warrants for 55,294.125 shares of Series B Preferred Stock that convert into shares of Common Stock and 396,633 shares of Common Stock issuable upon the exercise of warrants, all of which are immediately exercisable or exercisable within 60 days hereof); and (iii) 8,453 shares of Common Stock held by the Michael and Jane Hoffman 2013 Descendants Trust (Non-GST Exempt Trust), of which Mr. Hoffman is donor. /s/ Mark Guerin as attorney-in-fact 2018-08-29